Vaccines /
Vaccines /
edited by Stanley A. Plotkin, Walter A. Orenstein ; with assistance of Paul A. Offit.
- 4th ed.
- Philadelphia, Pa. : Saunders, c2004.
- xxi, 1662 p. : ill. ; 28 cm.
Includes bibliographical references and index.
Ch. 1. A short history of vaccination --
Ch. 2. The history of polio vaccine development --
Ch. 3. The immunology of vaccination --
Ch. 4. The vaccine industry --
Ch. 5. Vaccine manufacturing --
Ch. 6. Immunologic adjuvants --
Ch. 7. Vaccine additives and manufacturing residuals in the United States - licensed vaccines --
Ch. 8. General immunization practices --
Ch. 9. Smallpox and vaccinia --
Ch. 10. Vaccination in the immunocompromised host --
Ch. 11. Vaccination of human immunodeficiency virus-infected persons --
Ch. 12. Bacile Calmette-Guerin vaccine --
Ch. 13. Diphtheria toxoid --
Ch. 14. Haemophilus influenzae vaccine --
Ch. 15. Hepatitis A vaccine --
Ch. 16. Hepatitis B vaccine --
Ch. 17. Influenza vaccine-inactivated --
Ch. 18. Influenza vaccine-live --
Ch. 19. Measles vaccine --
Ch. 20. Mumps vaccine --
Ch. 21. Pertussis vaccine --
Ch. 22. Pneumococcal polysaccharide --
Ch. 23. Pneumococcal conjugate vaccine --
Ch. 24. Poliovirus vaccine-inactivated --
Ch. 25. Poliovirus vaccine-live --
Ch. 26. Rubella vaccine --
Ch. 27. Tetanus toxoid --
Ch. 28. Varicella vaccine --
Ch. 29. Combination vaccines --
Ch. 30. Adenovirus vaccine --
Ch. 31. Anthrax vaccine --
Ch. 32. Cholera vaccine --
Ch. 33. Japanese encephalitis vaccines --
Ch. 34. Meningococcal vaccines --
Ch. 35. Miscellaneous limited-use vaccines --
Ch. 36. Plague --
Ch. 37. Rabies vaccine --
38. Tick-borne encephalitis virus vaccine --
Ch. 39. Typhoid fever vaccine --
Ch. 40. Yellow fever vaccine --
Ch. 41. Technologies for making new vaccines --
Ch. 42. Cytomegalovirus and herpes simplex vaccines --
Ch. 43. Diarrheal disease vaccines --
Ch. 44. Human immunodeficiency virus --
Ch. 45. Human papillomavirus vaccine for cervical cancer prevention --
Ch. 46. Lyme disease vaccine --
Ch. 47. Malaria vaccine --
Ch. 48. Parasitic disease vaccines --
Ch. 49. Poxviruses as immunization vehicles --
Ch. 50. Respiratory syncytial virus vaccine --
Ch. 51. Rotavirus vaccine --
Ch. 52. Staphylococcus vaccine --
Ch. 53. Immunization in the United States --
Ch. 54. Immunization in Europe --
Ch. 55. Vaccination programs in developing countries --
Ch. 56. Community immunity --
Ch. 57. Economic analyses of vaccine policies --
Ch. 58. Vaccines for international travel --
Ch. 59. Vaccines for health care workers --
Ch. 60. Regulation and testing of vaccines --
Ch. 61. Safety of immunizations --
Ch. 62. Multiple vaccines and the immune system --
Ch. 63. Legal issues. TOC
This book examines every aspect of vaccination - from development to use in reducing disease. Completely revised and updated, it provides authoritative information on vaccine production, available preparations, efficacy, and safety-recommendations for vaccine use, with rationales-data on the impact of vaccination programs on morbidity and mortality-and more. The book provides a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health issues. It discusses the proper use of immune globulins and antitoxins; examines vaccine stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease control strategies; and illustrates concepts and objective data with over 605 tables and figures.
0721696880 9780721696881
2003042826
Vaccines.
Immunization Programs.
Vaccination.
QR189 / .V268 2004
615.372 / PLV 2004
QW 805 / V1163 2004
Includes bibliographical references and index.
Ch. 1. A short history of vaccination --
Ch. 2. The history of polio vaccine development --
Ch. 3. The immunology of vaccination --
Ch. 4. The vaccine industry --
Ch. 5. Vaccine manufacturing --
Ch. 6. Immunologic adjuvants --
Ch. 7. Vaccine additives and manufacturing residuals in the United States - licensed vaccines --
Ch. 8. General immunization practices --
Ch. 9. Smallpox and vaccinia --
Ch. 10. Vaccination in the immunocompromised host --
Ch. 11. Vaccination of human immunodeficiency virus-infected persons --
Ch. 12. Bacile Calmette-Guerin vaccine --
Ch. 13. Diphtheria toxoid --
Ch. 14. Haemophilus influenzae vaccine --
Ch. 15. Hepatitis A vaccine --
Ch. 16. Hepatitis B vaccine --
Ch. 17. Influenza vaccine-inactivated --
Ch. 18. Influenza vaccine-live --
Ch. 19. Measles vaccine --
Ch. 20. Mumps vaccine --
Ch. 21. Pertussis vaccine --
Ch. 22. Pneumococcal polysaccharide --
Ch. 23. Pneumococcal conjugate vaccine --
Ch. 24. Poliovirus vaccine-inactivated --
Ch. 25. Poliovirus vaccine-live --
Ch. 26. Rubella vaccine --
Ch. 27. Tetanus toxoid --
Ch. 28. Varicella vaccine --
Ch. 29. Combination vaccines --
Ch. 30. Adenovirus vaccine --
Ch. 31. Anthrax vaccine --
Ch. 32. Cholera vaccine --
Ch. 33. Japanese encephalitis vaccines --
Ch. 34. Meningococcal vaccines --
Ch. 35. Miscellaneous limited-use vaccines --
Ch. 36. Plague --
Ch. 37. Rabies vaccine --
38. Tick-borne encephalitis virus vaccine --
Ch. 39. Typhoid fever vaccine --
Ch. 40. Yellow fever vaccine --
Ch. 41. Technologies for making new vaccines --
Ch. 42. Cytomegalovirus and herpes simplex vaccines --
Ch. 43. Diarrheal disease vaccines --
Ch. 44. Human immunodeficiency virus --
Ch. 45. Human papillomavirus vaccine for cervical cancer prevention --
Ch. 46. Lyme disease vaccine --
Ch. 47. Malaria vaccine --
Ch. 48. Parasitic disease vaccines --
Ch. 49. Poxviruses as immunization vehicles --
Ch. 50. Respiratory syncytial virus vaccine --
Ch. 51. Rotavirus vaccine --
Ch. 52. Staphylococcus vaccine --
Ch. 53. Immunization in the United States --
Ch. 54. Immunization in Europe --
Ch. 55. Vaccination programs in developing countries --
Ch. 56. Community immunity --
Ch. 57. Economic analyses of vaccine policies --
Ch. 58. Vaccines for international travel --
Ch. 59. Vaccines for health care workers --
Ch. 60. Regulation and testing of vaccines --
Ch. 61. Safety of immunizations --
Ch. 62. Multiple vaccines and the immune system --
Ch. 63. Legal issues. TOC
This book examines every aspect of vaccination - from development to use in reducing disease. Completely revised and updated, it provides authoritative information on vaccine production, available preparations, efficacy, and safety-recommendations for vaccine use, with rationales-data on the impact of vaccination programs on morbidity and mortality-and more. The book provides a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health issues. It discusses the proper use of immune globulins and antitoxins; examines vaccine stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease control strategies; and illustrates concepts and objective data with over 605 tables and figures.
0721696880 9780721696881
2003042826
Vaccines.
Immunization Programs.
Vaccination.
QR189 / .V268 2004
615.372 / PLV 2004
QW 805 / V1163 2004